Mirjam 是一名药物代谢动力学顾问，在 Certara 公司担任美国药代动力学 II 部门总监。她拥有涵盖多种模式的专业知识，包括复杂生物制剂，并专注于细胞和基因疗法领域。Before joining Certara in 2022, Mirjam amassed over 18 years of experience in clinical pharmacology, pharmacometrics, and systems pharmacology, including more than five years focused on targeted radionuclide therapy (TRT) as well as cell and gene therapy.